PEAK6 Investments’s Ionis Pharmaceuticals IONS Stock Holding History

PEAK6 Investments’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,000	Closed	-$130K	–	3951
2024 Q1	$130K	Hold	3,000	–	–	﹤0.01%	3266
2023 Q4	$152K	Buy	+3,000	New	+$144K	﹤0.01%	3389
2021 Q1	–	Sell	-57,500	Closed	-$3.25M	–	5185
2020 Q4	$3.25M	Hold	57,500	–	–	0.01%	1436
2020 Q3	$2.73M	Hold	57,500	–	–	0.01%	1379
2020 Q2	$3.39M	Sell	57,500 -75,000	-57%	-$4.17M	0.01%	1074
2020 Q1	$6.26M	Sell	132,500 -38,800	-23%	-$2.16M	0.04%	451
2019 Q4	$10.3M	Sell	171,300 -47,900	-22%	-$2.85M	0.05%	361
2019 Q3	$13.1M	Buy	219,200 +95,700	+77%	+$6.24M	0.08%	261
2019 Q2	$7.94M	Buy	123,500 +34,600	+39%	+$2.45M	0.05%	459
2019 Q1	$7.22M	Buy	88,900 +6,400	+8%	+$413K	0.04%	515
2018 Q4	$4.46M	Buy	82,500 +2,000	+2%	+$102K	0.03%	712
2018 Q3	$4.15M	Buy	+80,500	New	+$3.78M	0.02%	899

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

PEAK6 Investments's IONS Position: Q3 2024 in Review

PEAK6 Investments reduced its Ionis Pharmaceuticals (IONS) stake by 10% in Q3 2024, selling an estimated $69.8K and leaving 13,500 shares worth $541K. The position accounts for ﹤0.01% of the portfolio, ranked #2266.

PEAK6 Investments first reported a position in IONS in Q3 2018 and has held it in 14 quarters since. The position peaked at $3.24M in Q3 2019. 353 funds tracked by Wall St. Rank hold IONS as of Q3 2024.

PEAK6 Investments held 13,500 shares of Ionis Pharmaceuticals worth $541K as of Q3 2024.
PEAK6 Investments sold 1,501 Ionis Pharmaceuticals shares in Q3 2024, an estimated $69.8K.
Ionis Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2266 holding.
PEAK6 Investments first reported a position in Ionis Pharmaceuticals in Q3 2018 and has held it in 14 quarters since.
PEAK6 Investments's Ionis Pharmaceuticals position peaked at $3.24M in Q3 2019.
353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.